10 Most Popular Funds in February 2017 (Taiwan Domiciled)

10 Most Searched for Taiwan Domiciled Funds by tw.morningstar.com users

Morningstar Editors 08 March, 2017 | 17:01
Facebook Twitter LinkedIn

1. Allianz Global Investors Target Income Fund B TWD

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28): Not Rated

2. Taishin High Dividend Yield Balanced Fund                           

Morningstar Category: TWD Moderate Allocation

Morningstar Rating (2017-02-28):Stars 5

3. ABITL Global High Yield Fund TA RMB

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28):Not Rated

4. ABITL Global High Yield Fund TA TWD

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28):Not Rated

5. Allianz Global Investors Taiwan Fund

Morningstar Category: Taiwan Small/Mid-Cap Equity

Morningstar Rating (2017-02-28):Stars 5

6. UBS (TW) Bond Fund - Asian High Yield - B

Morningstar Category: Asia High Yield Bond

Morningstar Rating (2017-01-31):Stars 3

7. Yuanta Global ETFs Stable Fund of Funds

Morningstar Category: Global Large-Cap Blend Equity

Morningstar Rating (2017-02-28):Stars 4

8. PineBridge Global Multi-Strategy High Yield Bond Fund B TWD

Morningstar Category: Global High Yield Bond

Morningstar Rating (2017-02-28):Stars 2

9. Allianz Global Investors Global Biotech Fund TWD

Morningstar Category: Sector Equity Biotechnology

Morningstar Rating (2017-02-28):Stars 3

10. Fuh Hwa Digital Economy Fund

Morningstar Category: Sector Equity Technology

Morningstar Rating (2017-02-28):Stars 4

 

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. 

 

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2022 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy